Table 2.
Demographic and clinical characteristics of randomized sample (N=49).
| Total (N=49) | Placebo (n=16) | Lorcaserin (n=33) | ||||
|---|---|---|---|---|---|---|
| Variables | n | Mean (SD) or % | n | Mean (SD) or % | n | Mean (SD) or % |
| Demographics | ||||||
| Age | 49 | 37.0 (10.9) | 16 | 39.5 (12.6) | 33 | 35.8 (9.9) |
| Gender | ||||||
| Male | 38 | 77.6% | 13 | 81.3% | 25 | 75.8% |
| Female | 11 | 22.4% | 3 | 18.8% | 8 | 24.2% |
| Race | ||||||
| White | 32 | 65.3% | 10 | 62.5% | 22 | 66.7% |
| Black | 9 | 18.4% | 4 | 25.0% | 5 | 15.2% |
| Asian | 1 | 2.0% | 1 | 6.3% | 0 | 0.0% |
| Other or More than 1 race | 3 | 6.1% | 0 | 0.0% | 3 | 9.1% |
| American Indian | 1 | 2.0% | 1 | 6.3% | 0 | 0.0% |
| Unknown | 3 | 6.1% | 0 | 0.0% | 3 | 9.1% |
| Ethnicity | ||||||
| Hispanic/Latino | 9 | 18.4% | 2 | 12.5% | 7 | 21.2% |
| Not Hispanic/Latino | 40 | 81.6% | 14 | 87.5% | 26 | 78.8% |
| Years of Education | 46 | 13.7 (2.2) | 14 | 14.3 (2) | 32 | 13.4 (2.3) |
| Marital Statusa | ||||||
| Single | 37 | 78.7% | 15 | 100.0% | 22 | 68.8% |
| Married | 6 | 12.8% | 0 | 0.0% | 6 | 18.8% |
| Separated | 1 | 2.1% | 0 | 0.0% | 1 | 3.1% |
| Divorced | 2 | 4.3% | 0 | 0.0% | 2 | 6.3% |
| Widowed | 1 | 2.1% | 0 | 0.0% | 1 | 3.1% |
| Employmenta | ||||||
| Full-Time | 14 | 29.8% | 5 | 33.3% | 9 | 28.1% |
| Part-Time | 4 | 8.5% | 2 | 13.3% | 2 | 6.3% |
| Unemployed | 26 | 55.3% | 7 | 46.7% | 19 | 59.4% |
| Disabled | 1 | 2.1% | 0 | 0.0% | 1 | 3.1% |
| Other | 2 | 4.3% | 1 | 6.7% | 1 | 3.1% |
| Opiate use | ||||||
| Severity of Use | ||||||
| Low (≤200mg or ≤5 bags) | 13 | 26.5% | 5 | 31.3% | 8 | 24.2% |
| High (>200mg or >5 bags) | 36 | 73.5% | 11 | 68.8% | 25 | 75.8% |
| Type of Opiate at Screening | ||||||
| Heroin | 39 | 79.6% | 12 | 75.0% | 27 | 81.8% |
| Opioid pills | 10 | 20.4% | 4 | 25.0% | 6 | 18.2% |
| Type of Opiate at Screening with Fentanyl Status | ||||||
| Fentanyl-negative opioid pills | 10 | 20.4% | 4 | 25.0% | 6 | 18.2% |
| Fentanyl-negative heroin | 5 | 10.2% | 0 | 0.0% | 5 | 15.2% |
| Fentanyl-positive heroin | 28 | 57.1% | 10 | 62.5% | 18 | 54.5% |
| Fentanyl-unknown heroin | 6 | 12.2% | 2 | 12.5% | 4 | 12.1% |
| Route of Use | ||||||
| IN | 28 | 57.1% | 9 | 56.’% | 19 | 57.6% |
| IV | 10 | 20.4% | 2 | 12.5% | 8 | 24.2% |
| PO | 8 | 16.3% | 4 | 25.0% | 4 | 12.1% |
| smoked | 3 | 6.1% | 1 | 6.3% | 2 | 6.1% |
| Dropped before 8 weeks | ||||||
| No | 9 | 18.4% | 3 | 18.8% | 6 | 18.2% |
| Yes | 40 | 81.6% | 13 | 81.3% | 27 | 81.8% |
a
2 subjects were missing employment and marital status info, Total N=47, Placebo n=15, Lorcaserin n=32.